California State Teachers Retirement System Vertex Pharmaceuticals Inc Transaction History

California State Teachers Retirement System

  • $83.3 Billion
  • Q4 2024

A detailed history of California State Teachers Retirement System transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, California State Teachers Retirement System holds 400,670 shares of VRTX stock, worth $191 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
400,670
Previous 400,670 -0.0%
Holding current value
$191 Million
Previous $161 Million -0.0%
% of portfolio
0.19%
Previous 0.19%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$396.64 - $516.74 $4.68 Million - $6.1 Million
-11,807 Reduced 2.86%
400,670 $161 Million
Q3 2024

Apr 04, 2025
BUY
$460.0 - $505.78 $5.43 Million - $5.97 Million
11,807 Added 2.95%
412,477 $192 Million
Q3 2024

Nov 14, 2024
SELL
$460.0 - $505.78 $1.57 Million - $1.72 Million
-3,409 Reduced 0.82%
412,477 $192 Million
Q2 2024

Apr 08, 2025
BUY
$392.81 - $485.53 $5.98 Million - $7.39 Million
15,216 Added 3.8%
415,886 $195 Million
Q2 2024

Aug 14, 2024
SELL
$392.81 - $485.53 $422,663 - $522,430
-1,076 Reduced 0.26%
415,886 $195 Million
Q1 2024

May 15, 2024
BUY
$407.69 - $446.08 $930,348 - $1.02 Million
2,282 Added 0.55%
416,962 $174 Million
Q4 2023

Feb 13, 2024
BUY
$343.0 - $410.68 $1.98 Million - $2.38 Million
5,787 Added 1.42%
414,680 $169 Million
Q3 2023

Nov 14, 2023
SELL
$338.18 - $362.46 $5.51 Million - $5.9 Million
-16,284 Reduced 3.83%
408,893 $142 Million
Q2 2023

Aug 21, 2023
SELL
$314.42 - $351.91 $2.5 Million - $2.8 Million
-7,960 Reduced 1.84%
425,177 $150 Million
Q1 2023

May 09, 2023
SELL
$283.23 - $323.1 $1.1 Million - $1.25 Million
-3,878 Reduced 0.89%
433,137 $136 Million
Q4 2022

Feb 14, 2023
BUY
$285.76 - $321.48 $2 Million - $2.25 Million
6,996 Added 1.63%
437,015 $126 Million
Q3 2022

Nov 18, 2022
SELL
$273.83 - $305.53 $926,093 - $1.03 Million
-3,382 Reduced 0.78%
430,019 $125 Million
Q2 2022

Aug 15, 2022
BUY
$234.96 - $292.55 $992,471 - $1.24 Million
4,224 Added 0.98%
433,401 $122 Million
Q1 2022

May 16, 2022
SELL
$221.42 - $260.97 $7.12 Million - $8.4 Million
-32,170 Reduced 6.97%
429,177 $112 Million
Q4 2021

Feb 15, 2022
BUY
$177.01 - $223.45 $2.26 Million - $2.85 Million
12,765 Added 2.85%
461,347 $101 Million
Q3 2021

Nov 15, 2021
SELL
$181.39 - $202.99 $1.66 Million - $1.86 Million
-9,144 Reduced 2.0%
448,582 $81.4 Million
Q2 2021

Aug 16, 2021
SELL
$187.49 - $221.1 $5.41 Million - $6.38 Million
-28,838 Reduced 5.93%
457,726 $92.3 Million
Q1 2021

May 18, 2021
BUY
$207.02 - $241.31 $23,600 - $27,509
114 Added 0.02%
486,564 $105 Million
Q4 2020

Feb 16, 2021
BUY
$207.01 - $276.09 $2.72 Million - $3.62 Million
13,126 Added 2.77%
486,450 $115 Million
Q3 2020

Nov 17, 2020
BUY
$255.65 - $303.1 $1.16 Million - $1.38 Million
4,537 Added 0.97%
473,324 $129 Million
Q2 2020

Aug 17, 2020
BUY
$225.48 - $295.8 $86,809 - $113,883
385 Added 0.08%
468,787 $136 Million
Q1 2020

May 13, 2020
BUY
$199.77 - $247.81 $801,677 - $994,461
4,013 Added 0.86%
468,402 $111 Million
Q4 2019

Feb 14, 2020
BUY
$166.71 - $223.91 $5.9 Million - $7.92 Million
35,393 Added 8.25%
464,389 $102 Million
Q3 2019

Nov 15, 2019
BUY
$166.23 - $187.09 $866,723 - $975,487
5,214 Added 1.23%
428,996 $72.7 Million
Q2 2019

Aug 14, 2019
BUY
$164.61 - $190.37 $767,411 - $887,504
4,662 Added 1.11%
423,782 $77.7 Million
Q1 2019

May 09, 2019
BUY
$163.73 - $194.7 $329,261 - $391,541
2,011 Added 0.48%
419,120 $77.1 Million
Q4 2018

Feb 13, 2019
BUY
$151.91 - $192.21 $1.41 Million - $1.79 Million
9,288 Added 2.28%
417,109 $69.1 Million
Q3 2018

Nov 14, 2018
SELL
$167.73 - $192.74 $3,857 - $4,433
-23 Reduced 0.01%
407,821 $78.6 Million
Q2 2018

Aug 14, 2018
BUY
$145.72 - $169.96 $915,267 - $1.07 Million
6,281 Added 1.56%
407,844 $69.3 Million
Q1 2018

May 15, 2018
SELL
$151.6 - $177.13 $2.1 Million - $2.46 Million
-13,877 Reduced 3.34%
401,563 $65.4 Million
Q4 2017

Feb 14, 2018
SELL
$137.28 - $155.55 $729,780 - $826,903
-5,316 Reduced 1.26%
415,440 $62.3 Million
Q3 2017

Nov 13, 2017
BUY
$148.13 - $162.24 $62.3 Million - $68.3 Million
420,756
420,756 $64 Million

Others Institutions Holding VRTX

# of Institutions
1,784
Shares Held
224M
Call Options Held
1.63M
Put Options Held
1.47M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $123B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email